(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 7.85% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23%.
Stepan Co's revenue in 2026 is $2,303,837,000.On average, 3 Wall Street analysts forecast SCL's revenue for 2026 to be $58,017,773,475, with the lowest SCL revenue forecast at $55,868,967,050, and the highest SCL revenue forecast at $60,777,293,305. On average, 3 Wall Street analysts forecast SCL's revenue for 2027 to be $60,732,055,275, with the lowest SCL revenue forecast at $58,289,201,655, and the highest SCL revenue forecast at $63,808,241,315.
In 2028, SCL is forecast to generate $65,957,047,740 in revenue, with the lowest revenue forecast at $64,011,812,450 and the highest revenue forecast at $68,580,853,480.